Daniel Zagury

Person

Paris, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Method of inhibiting HIV-1 viral rebound in a subject using interfe...
- Patent number 12,024,558
- Issue date Jul 2, 2024
- 21C Bio
- Daniel Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cel...
- Patent number 11,365,392
- Issue date Jun 21, 2022
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Daniel Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic...
- Patent number 11,198,851
- Issue date Dec 14, 2021
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERE MEDICALE)
- Daniel Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccine to pathogenic immune activation cells during infections
- Patent number 11,077,185
- Issue date Aug 3, 2021
- 21C Bio
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccine to pathogenic immune activation cells during infections
- Patent number 10,632,186
- Issue date Apr 28, 2020
- 21C Bio
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable immunogenic product comprising antigenic heterocomplexes
- Patent number 8,697,047
- Issue date Apr 15, 2014
- Neovacs
- Helene Le Buannec
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High-yield method for the production of human antibodies blocking t...
- Patent number 8,679,483
- Issue date Mar 25, 2014
- Neovacs
- Bernard Bizzini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for preparing a stable TNF-α vaccine
- Patent number 8,372,388
- Issue date Feb 12, 2013
- Neovacs
- Hélène Le Buanec
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of immunogens to treat or prevent, in malignant tumors, the imm...
- Patent number 8,101,165
- Issue date Jan 24, 2012
- Neovacs
- Jean Francois Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable immunogenic product comprising antigenic heterocomplexes
- Patent number 7,972,603
- Issue date Jul 5, 2011
- Neovacs
- Helene Le Buannec
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for preparing a stable immunogenic product comprising antige...
- Patent number 7,887,811
- Issue date Feb 15, 2011
- Neovacs
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of immunogenic immunosuppressive and/or angiogenic proteins whi...
- Patent number 7,504,479
- Issue date Mar 17, 2009
- Neovacs
- Daniel A. Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of inactive immunosuppressive and/or angiogenic immunogenic pro...
- Patent number 7,351,554
- Issue date Apr 1, 2008
- Neovacs
- Daniel Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Non-immunosuppressive immunogenic or vaccine composition comprising...
- Patent number 7,314,629
- Issue date Jan 1, 2008
- Neovacs
- Daniel Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chemically modified cytokines
- Patent number 7,208,148
- Issue date Apr 24, 2007
- Neovacs S.A.
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for determining prognosis of HIV infected individuals
- Patent number 7,067,246
- Issue date Jun 27, 2006
- Neovacs S.A.
- Daniel Zagury
- G01 - MEASURING TESTING
Information Patent Grant
Use of immunogenic immunosuppressive and/or angiogenic proteins whi...
- Patent number 7,022,482
- Issue date Apr 4, 2006
- Neovacs
- Daniel A. Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of inactivated immunosuppressive or angiogenic immunogenic prot...
- Patent number 7,015,016
- Issue date Mar 21, 2006
- Neovacs
- Daniel Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chemically modified TNF-α
- Patent number 6,878,370
- Issue date Apr 12, 2005
- Neovacs
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunogenic compounds with in particular an anti-cytokine effect, p...
- Patent number 6,455,045
- Issue date Sep 24, 2002
- Neovacs
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of alicyclic diamines as immunomodulators
- Patent number 6,228,890
- Issue date May 8, 2001
- Neovacs
- Jean-Claude Maziere
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-toxic immunogens derived from a retroviral regulatory protein a...
- Patent number 6,200,575
- Issue date Mar 13, 2001
- Neovacs
- Jean-François Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-Toxic immunogens derived from a retroviral regulatory protein,...
- Patent number 6,132,721
- Issue date Oct 17, 2000
- Neovacs
- Jean-Fran.cedilla.ois Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inactive but immunogenic cytokines, pharmaceutical compositions con...
- Patent number 6,093,405
- Issue date Jul 25, 2000
- Neovacs
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
POPULATION OF TREG CELLS FUNCTIONALLY COMMITTED TO EXERT A REGULATO...
- Publication number 20230323299
- Publication date Oct 12, 2023
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCH MEDICALE)
- Hélène LE BUANEC
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EX VIVO GENERATION OF GAMMA DELTA FOXP3+ REGULATORY T CELLS AND THE...
- Publication number 20220119766
- Publication date Apr 21, 2022
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Daniel ZAGURY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF CD26 AND CD39 AS NEW PHENOTYPIC MARKERS FOR ASSESSING MATURA...
- Publication number 20220018835
- Publication date Jan 20, 2022
- Inserm (Institut National de la Sante et de la Recherche Medicale
- Daniel ZAGURY
- G01 - MEASURING TESTING
Information Patent Application
NOVEL COMBINATION FOR THE TREATMENT OF AIDS
- Publication number 20210332127
- Publication date Oct 28, 2021
- 21C Bio
- Daniel ZAGURY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VACCINE TO PATHOGENIC IMMUNE ACTIVATION CELLS DURING INFECTIONS
- Publication number 20210322538
- Publication date Oct 21, 2021
- 21C Bio
- Daniel ZAGURY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINE TO PATHOGENIC IMMUNE ACTIVATION CELLS DURING INFECTIONS
- Publication number 20200297837
- Publication date Sep 24, 2020
- 21C Bio
- Daniel ZAGURY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPEUTIC USES OF EX VIVO GENERATED FOXP3+ REGULATORY T CELLS
- Publication number 20190167791
- Publication date Jun 6, 2019
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Daniel ZAGURY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EX VIVO GENERATION OF MHCII RESTRICTED CD4+FOXP3+ REGULATORY T CELL...
- Publication number 20190161728
- Publication date May 30, 2019
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Daniel ZAGURY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EX VIVO GENERATION OF GAMMA DELTA FOXP3+ REGULATORY T CELLS AND THE...
- Publication number 20190161729
- Publication date May 30, 2019
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Daniel ZAGURY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES
- Publication number 20110250174
- Publication date Oct 13, 2011
- NEOVACS
- Helene LE BUANNEC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for Preparing a Stable Immunogenic Product Comprising Antige...
- Publication number 20080193473
- Publication date Aug 14, 2008
- NEOVACS
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of immunogens to treat or prevent, in malignant tumors, the imm...
- Publication number 20080031849
- Publication date Feb 7, 2008
- NEOVACS
- Jean-Francois ZAGURY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High-Yield Method For The Production Of Human Antibodies Blocking T...
- Publication number 20070202102
- Publication date Aug 30, 2007
- NEOVACS
- Bernard Bizzini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for monitoring anti-HIV treatment in HIV infected individuals
- Publication number 20060252075
- Publication date Nov 9, 2006
- NEOVACS
- Daniel Zagury
- G01 - MEASURING TESTING
Information Patent Application
Non-immunosuppressive imunogenic or vaccine composition comprising...
- Publication number 20060233820
- Publication date Oct 19, 2006
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of inactive immunosuppressive and/or angiogenic immunogenic pro...
- Publication number 20060153863
- Publication date Jul 13, 2006
- NEOVACS
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of immunogenic immunosuppressive and/or angiogenic proteins whi...
- Publication number 20060153862
- Publication date Jul 13, 2006
- NEOVACS
- Daniel A. Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stable immunogenic product comprising antigenic heterocomplexes
- Publication number 20060067944
- Publication date Mar 30, 2006
- Helene Le Buannec
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stable immunogenic product comprising antigenic heterocomplexes
- Publication number 20060013800
- Publication date Jan 19, 2006
- Helene Le Buanec
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chemically modified TNF-alpha
- Publication number 20050180950
- Publication date Aug 18, 2005
- NEOVACS
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Composite superimmunogen for bi-functional vaccine use for the trea...
- Publication number 20040185058
- Publication date Sep 23, 2004
- Daniel Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Vaccines against cytokines and growth factors derived from malignan...
- Publication number 20040028647
- Publication date Feb 12, 2004
- Jean-Francois Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of immunogenic immunosuppressive and/or angiogenic proteins whi...
- Publication number 20040001852
- Publication date Jan 1, 2004
- NEOVACS 11, RUE PERNETY
- Daniel A. Zagury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of inactivated immunosuppressive or angiogenic immunogenic prot...
- Publication number 20030003106
- Publication date Jan 2, 2003
- Daniel Zagury
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Daniel Zagury

Person

Patents Grantslast 30 patents

Method of inhibiting HIV-1 viral rebound in a subject using interfe...

Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cel...

Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic...

Vaccine to pathogenic immune activation cells during infections

Vaccine to pathogenic immune activation cells during infections

Stable immunogenic product comprising antigenic heterocomplexes

High-yield method for the production of human antibodies blocking t...

Method for preparing a stable TNF-α vaccine

Use of immunogens to treat or prevent, in malignant tumors, the imm...

Stable immunogenic product comprising antigenic heterocomplexes

Method for preparing a stable immunogenic product comprising antige...

Use of immunogenic immunosuppressive and/or angiogenic proteins whi...

Use of inactive immunosuppressive and/or angiogenic immunogenic pro...

Non-immunosuppressive immunogenic or vaccine composition comprising...

Chemically modified cytokines

Method for determining prognosis of HIV infected individuals

Use of immunogenic immunosuppressive and/or angiogenic proteins whi...

Use of inactivated immunosuppressive or angiogenic immunogenic prot...

Chemically modified TNF-α

Immunogenic compounds with in particular an anti-cytokine effect, p...

Use of alicyclic diamines as immunomodulators

Non-toxic immunogens derived from a retroviral regulatory protein a...

Non-Toxic immunogens derived from a retroviral regulatory protein,...

Inactive but immunogenic cytokines, pharmaceutical compositions con...

Patents Applicationslast 30 patents

POPULATION OF TREG CELLS FUNCTIONALLY COMMITTED TO EXERT A REGULATO...

EX VIVO GENERATION OF GAMMA DELTA FOXP3+ REGULATORY T CELLS AND THE...

USE OF CD26 AND CD39 AS NEW PHENOTYPIC MARKERS FOR ASSESSING MATURA...

NOVEL COMBINATION FOR THE TREATMENT OF AIDS

VACCINE TO PATHOGENIC IMMUNE ACTIVATION CELLS DURING INFECTIONS

VACCINE TO PATHOGENIC IMMUNE ACTIVATION CELLS DURING INFECTIONS

IMMUNOTHERAPEUTIC USES OF EX VIVO GENERATED FOXP3+ REGULATORY T CELLS

EX VIVO GENERATION OF MHCII RESTRICTED CD4+FOXP3+ REGULATORY T CELL...

EX VIVO GENERATION OF GAMMA DELTA FOXP3+ REGULATORY T CELLS AND THE...

STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES

Method for Preparing a Stable Immunogenic Product Comprising Antige...

Use of immunogens to treat or prevent, in malignant tumors, the imm...

High-Yield Method For The Production Of Human Antibodies Blocking T...

Method for monitoring anti-HIV treatment in HIV infected individuals

Non-immunosuppressive imunogenic or vaccine composition comprising...

Use of inactive immunosuppressive and/or angiogenic immunogenic pro...

Use of immunogenic immunosuppressive and/or angiogenic proteins whi...

Stable immunogenic product comprising antigenic heterocomplexes

Stable immunogenic product comprising antigenic heterocomplexes

Chemically modified TNF-alpha

Composite superimmunogen for bi-functional vaccine use for the trea...

Vaccines against cytokines and growth factors derived from malignan...

Use of immunogenic immunosuppressive and/or angiogenic proteins whi...

Use of inactivated immunosuppressive or angiogenic immunogenic prot...